RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TEVA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Teva Pharmaceutical Industries Limited stock downgraded after the last trading session.
(Updated on Mar 28, 2024)

Buy or Hold candidate since Dec 19, 2023 Gain 32.74% PDF

The Teva Pharmaceutical Industries Limited stock price fell by -2.22% on the last day (Thursday, 28th Mar 2024) from $14.43 to $14.11. During the last trading day the stock fluctuated 3.15% from a day low at $13.97 to a day high of $14.41. The price has risen in 7 of the last 10 days and is up by 4.52% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 10 million shares were bought and sold for approximately $144.58 million.

The stock lies in the middle of a strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 30.43% during the next 3 months and, with a 90% probability hold a price between $17.87 and $18.89 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TEVA Signals & Forecast

The Teva Pharmaceutical Industries Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $13.98 and $13.36. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -2.22%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Teva Pharmaceutical Industries Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at $12.10 and $11.73. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Teva Pharmaceutical Industries Limited finds support just below today's level at $12.10. If this is broken, then the next support from accumulated volume will be at $11.73 and $11.49.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.440 (3.15%) between high and low. For the last week, the stock has had daily average volatility of 2.23%.

Our recommended stop-loss: $13.46 (-4.62%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (TEVA) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Teva Pharmaceutical Industries Limited to open at $14.16, and during the day (based on 14 day Average True Range), to move between $13.78 and $14.44, which gives a possible trading interval of +/-$0.334 (+/-2.37%) up or down from last closing price. If Teva Pharmaceutical Industries Limited takes out the full calculated possible swing range there will be an estimated 4.73% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.14 (0.21%) than the support at $12.10 (14.25%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Teva Pharmaceutical Industries Limited stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Teva Pharmaceutical Industries Limited stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 1.510 Buy Candidate Downgraded

Predicted Opening Price for Teva Pharmaceutical Industries Limited of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$14.16 ( 0.378%) $14.11

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TEVA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 14.60 3.50 %
R2 14.44 2.31 %
R1 14.33 1.57 %
Current price: 14.11
Support S1 14.00 -0.81 %
S2 13.89 -1.55 %
S3 13.72 -2.74 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 14.43 2.27 %
R1 14.14 0.213 %
Current price 14.11
Support S1 12.10 -14.25%
S2 11.73 -16.87%
S3 11.49 -18.57%

TEVA Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Nov 02, 2017 Nov 27, 2017 Dec 12, 2017 $0.0850 0.515%
2 Aug 07, 2017 Aug 25, 2017 Sep 14, 2017 $0.0850 0.463%
3 May 11, 2017 Jun 01, 2017 Jun 22, 2017 $0.340 1.05%
4 Feb 13, 2017 Feb 28, 2017 Mar 20, 2017 $0.340 1.01%
5 Nov 15, 2016 Dec 01, 2016 Dec 20, 2016 $0.340 0.94%

FAQ

What is the symbol for Teva Pharmaceutical Industries Limited Stock and on which exchange is it traded?
The symbol for Teva Pharmaceutical Industries Limited is TEVA and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Teva Pharmaceutical Industries Limited Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Teva Pharmaceutical Industries Limited stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

How to buy Teva Pharmaceutical Industries Limited Stock?
Teva Pharmaceutical Industries Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Teva Pharmaceutical Industries Limited Stock.

What's the current price of Teva Pharmaceutical Industries Limited Stock?
As of the end of day on the 2024-03-28, the price of an Teva Pharmaceutical Industries Limited (TEVA) share was $14.11.

What is the 52-week high and low for Teva Pharmaceutical Industries Limited Stock?
The 52-week high for Teva Pharmaceutical Industries Limited Stock is $14.45 and the 52-week low is $7.09.

What is the market capitalization of Teva Pharmaceutical Industries Limited Stock?
As of the 2024-03-28, the market capitalization of Teva Pharmaceutical Industries Limited is 16.176B.

When is the next earnings date for Teva Pharmaceutical Industries Limited?
The upcoming earnings date for Teva Pharmaceutical Industries Limited is May 08, 2024.
Click to get the best stock tips daily for free!

About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and cr... TEVA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT